-
Apr 19 2011FDA Chief Counsel Report – How to Deal With and Avoid Warning Letters | Jan. 10, 2012, 2-3 PM EDT| Bradshaw
-
Apr 14 2011FDA opts for “effective remedy” with Triad
-
Feb 6 2012Johnson & Johnson hit with FDA warning letter
-
Feb 6 2012Cardinal Health Inc. Pharmaceutical’s Work Suspended
-
Feb 6 2012Unions Vow To Fight AstraZeneca Job Cuts
-
Feb 6 2012Lilly Freezes Salaries For Most Employees
-
Feb 3 2012Insight: In PIP implant scandal, a ragged safety net exposed
-
Feb 3 2012Whistleblowers accuse FDA of spying, persecution
-
Feb 3 2012Drug Shortages Cause Cancer Patients To Die Sooner
-
Feb 3 2012FDA Commish: COI Rules Should Remain Intact
-
Feb 2 2012Pfizer Cites Packaging Flaws in Birth-Control Pill Recall
-
Feb 2 2012FDA Review Deadlines Caused Safety Issues: Study
-
Feb 2 2012About Those 7,300 AstraZeneca Job Cuts…
-
Feb 2 2012The Pfizer Generation: Who Pays For The Babies?
-
Feb 2 2012Grassley Probes FDA Over Employee Whistleblowers
-
Feb 1 2012Whistleblowers Sue FDA, Claim Emails Monitored
-
Feb 1 2012Merck increasing animal health business operations in Summit
-
Feb 1 2012Family sues after teen dies following HPV vaccination
-
Feb 1 2012J&J Reorganizes Consumer Health Unit, Again
-
Feb 1 2012Takeda Hid Harmful Drug Interactions: Consultant
-
Feb 1 2012Pfizer Recalls Birth Control Pills Dosage Mix-Up
-
Jan 31 2012FDA Accused of Spying on Staff Over Complaints to Congress
-
Jan 31 2012FDA Sued By Employees Over Email Privacy
-
Jan 31 2012Bob Temple Changes His Role At FDA, Again
-
Jan 31 2012What Dogs? Novartis, Vets And Product Mix-Ups
-
Jan 30 2012Compliant Safety Reporting in Clinical Trials – Are You Following FDA Rules? | March 7, 2012, 2-3 PM EST
-
Jan 30 2012Teva’s Cephalon recalls Treanda leukemia drug due to glass fragments
-
Jan 30 2012Pfizer Sued By Employees Over Retirement Plans
-
Jan 30 2012160 Novartis Temporary Employees Without Jobs
-
Jan 30 2012AstraZeneca May Shed Thousands More Jobs
-
Jan 26 2012FDA dings Hospira for ‘misleading’ ads for blood drug
-
Jan 26 2012EU could make API suppliers verify starting material sources
-
Jan 26 2012Ranbaxy Labs Gets A Sweeping Consent Decree
-
Jan 26 2012Celgene To The FDA: Oh… That White Paper
-
Jan 25 2012Pakistan Arrests Pharma Execs Over Patient Deaths
-
Jan 25 2012Paula Deen Publicist Quits Over Novo Nordisk Deal
-
Jan 25 2012Fabry Patients Press Lawsuit Despite Plant Approval
-
Jan 25 2012Lonza boots out CEO as 2011 profit plunges
-
Jan 25 2012Bristol-Myers, FDA & A Lack Of Safety Warnings
-
Jan 24 2012Top Compliance Trends for 483 and Warning Letters for 2012 – Based on Rare FDA Data | March, 8, 2012, 2-3:30 PM EST | Moore
-
Jan 23 2012FDA Blasts DePuy Orthopaedics Over Regulatory Problems
-
Jan 23 2012FDA Warnings Are Often Ignored or Misinterpreted
-
Jan 23 2012FDA May Approve Pot-Based Prescription Drugs
-
Jan 23 2012BioMarin’s Dwarfism Medicine Marks Growth of $400,000 Rare-Disease Drugs
-
Jan 23 2012Roche Meds In Short Supply Over Plant Problems
-
Jan 20 2012Drug lobby wants clearer FDA rules for diet pills
-
Jan 20 2012The Wiseguys Are Stealing Fewer Pharmaceuticals
-
Jan 20 2012EMA Probes Novartis MS Pill Over Deaths
-
Jan 20 2012Novo Must Get Rid Of Paula Deen: Kliff Explains
-
Jan 19 2012FDA warns J&J’s DePuy for selling unapproved device components
-
Jan 19 2012The Controversial Death Of A Sanofi Sales Rep
-
Jan 19 2012J&J Hid 3 Risperdal Diabetes Studies From FDA, Texas Jury Told
-
Jan 19 2012Bristol-Myers In Hot Water Over Boiled Monkey?
-
Jan 18 2012Novartis Reverses Plant Closure In Switzerland
-
Jan 18 2012Chef of Unhealthy Foods Is Now Spokesperson for Novo Nordisk
-
Jan 18 2012Takeda Plans To Cut 2,800 Jobs In US & Europe
-
Jan 18 2012Sanofi Chemist Admits To Stealing Trade Secrets
-
Jan 17 2012ARC Warning Letter and 483
-
Jan 17 2012FDA fines Red Cross nearly $9.6 million for blood safety lapses
-
Jan 17 2012Novartis rep: There’s no deal with Paula Deen
-
Jan 17 2012Daiichi Sankyo officials to monitor new Ranbaxy unit
-
Jan 17 2012Roche Refuses To Disclose Tamiflu Data: Scientists
